SCHEMBL6545313

SCHEMBL6545313

O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Br)ccc2O)c1O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EEF2K O00418 1/20 0.79
PLK4 O00444 1/20 0.79
IKBKB O14920 1/20 0.79
DYRK3 O43781 1/20 0.79
PIM1 P11309 1/20 0.79
CDK2 P24941 1/20 0.79
AKT1 P31749 1/20 0.79
AKT2 P31751 1/20 0.79
CLK2 P49760 1/20 0.79
GSK3B P49841 1/20 0.79
IRAK1 P51617 1/20 0.79
RPS6KA3 P51812 1/20 0.79
NEK4 P51957 1/20 0.79
PLK1 P53350 1/20 0.79
CSNK2A1 P68400 1/20 0.79
CDK5 Q00535 1/20 0.79
MAP4K2 Q12851 1/20 0.79
PAK1 Q13153 1/20 0.79
CAMK2B Q13554 1/20 0.79
CAMK2G Q13555 1/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6545590 0.88 EEF2K (1.00) EEF2KPLK4IKBKBDYRK3PIM1
SCHEMBL6545791 0.84 EEF2K (0.57) EEF2KPLK4IKBKBDYRK3PIM1
SCHEMBL6545441 0.77 GSK3B (0.60) EEF2KPLK4IKBKBDYRK3PIM1
SCHEMBL6545662 0.77 GSK3B (0.49) EEF2KPLK4IKBKBDYRK3PIM1
SCHEMBL8481050 0.75 PIM1 (0.76) EEF2KPLK4IKBKBDYRK3PIM1
SCHEMBL6545665 0.72 EEF2K (0.71) EEF2KPLK4IKBKBDYRK3PIM1
SCHEMBL6546279 0.71 EEF2K (0.71) EEF2KPLK4IKBKBDYRK3PIM1
SCHEMBL6545356 0.69 CYP2C9 (0.56) EEF2KPLK4IKBKBDYRK3PIM1
SCHEMBL6545953 0.69 BIRC5 (0.46) EEF2KPLK4IKBKBDYRK3PIM1
SCHEMBL9007833 0.68 GRIN2D (0.59) EEF2KPLK4IKBKBDYRK3PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0942723-B1 4-ARYL-3-HYDROXYQUINOLIN-2-ONE DERIVATIVES AS ION CHANNEL MODULATORS BRISTOL MYERS SQUIBB CO (US) 2004-01-21 EP claimed
EP-0942723-A4 4-ARYL-3-HYDROXYQUINOLIN-2-ONE DERIVATIVES AS ION CHANNEL MODULATORS BRISTOL MYERS SQUIBB CO (US) 2002-05-15 EP claimed
EP-0942723-A1 4-ARYL-3-HYDROXYQUINOLIN-2-ONE DERIVATIVES AS ION CHANNEL MODULATORS Bristol-Myers Squibb Company (US) 1999-09-22 EP claimed
US-5922735-A CALCIUM-ACTIVATED POTASSIUM CHANNELS AND ARE USEFUL TREATING THE DISORDER RESPONSIVE TO THE OPENING OF THE POTASSIUM CHANNELS SUCH AS ISCHEMIA, CONVULSIONS, ASTHMA, IRRITABLE BOWEL SYNDROME, MIGRAINE, TRAUMATIC BRAIN INJURY BRISTOL-MYERS SQUIBB COMPANY (US) 1999-07-13 US claimed
US-5892045-A 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators BRISTOL-MYERS SQUIBB COMPANY (US) 1999-04-06 US claimed
WO-1998023273-A1 4-ARYL-3-HYDROXYQUINOLIN-2-ONE DERIVATIVES AS ION CHANNEL MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-06-04 WO claimed